| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Air pollution and multiple sclerosis risk
|
Giovannoni, Gavin
|
|
|
48 |
C |
p.
|
artikel
|
| 2 |
A literature review of biosensors for multiple sclerosis: Towards personalized medicine and point-of-care testing
|
Can Demirdöğen, Birsen
|
|
|
48 |
C |
p.
|
artikel
|
| 3 |
Altered structural networks in neuromyelitis optica spectrum disorder related with cognition impairment and clinical features
|
Zheng, Qiao
|
|
|
48 |
C |
p.
|
artikel
|
| 4 |
Anti-MOG associated disorder–Clinical and radiological characteristics compared to AQP4-IgG+ NMOSD–A single-center experience
|
Rempe, Torge
|
|
|
48 |
C |
p.
|
artikel
|
| 5 |
A randomised controlled trial to test the feasibility of online mindfulness programs for people with multiple sclerosis
|
Dunne, Jennifer
|
|
|
48 |
C |
p.
|
artikel
|
| 6 |
Association between IL7 Receptor Alpha (Il7ra) gene rs6897932 polymorphism and the risk of Multiple Sclerosis: A meta-regression and meta-analysis.
|
Omraninava, Melodi
|
|
|
48 |
C |
p.
|
artikel
|
| 7 |
Association of Multiple Sclerosis with PM 2.5 levels. Further evidence from the highly polluted area of Padua Province, Italy
|
Scartezzini, Arianna
|
|
|
48 |
C |
p.
|
artikel
|
| 8 |
Associations between cognitive and clinical disability across MS subtypes: The role of the underlying brain damage
|
Gois, Larissa Carla de Paula
|
|
|
48 |
C |
p.
|
artikel
|
| 9 |
Babesia microti infection in a patient with multiple sclerosis treated with ocrelizumab
|
Haberli, Nicholas
|
|
|
48 |
C |
p.
|
artikel
|
| 10 |
Comorbidity in multiple sclerosis patients from Nordland County, Norway – validated data from the Norwegian Patient Registry
|
Benjaminsen, Espen
|
|
|
48 |
C |
p.
|
artikel
|
| 11 |
Corrigendum to demographic and clinical characterization of multiple sclerosis in Mexico: The Remember study multiple sclerosis and related disorders volume (2020) MSARD-D-20-00380R3 [201111-021909]
|
Bertado-Cortés, Brenda
|
|
|
48 |
C |
p.
|
artikel
|
| 12 |
Corrigendum to Myelin Oligodendrocyte Glycoprotein Antibody Associated Central Nervous System Demyelinating Disease: A Tertiary Center Experience From Turkey [Multiple Sclerosis and Related Disorders 44 (2020) 102376]
|
Inan, Berin
|
|
|
48 |
C |
p.
|
artikel
|
| 13 |
COVID-19 in teriflunomide-treated patients with multiple sclerosis: A case report and literature review
|
Capone, Fioravante
|
|
|
48 |
C |
p.
|
artikel
|
| 14 |
CSF levels of HoxB3 and YKL-40 may predict conversion from clinically isolated syndrome to relapsing remitting multiple sclerosis
|
Tamam, Yusuf
|
|
|
48 |
C |
p.
|
artikel
|
| 15 |
CSF plasmablasts differentiate MS from other neurologic disorders
|
Kister, I.
|
|
|
48 |
C |
p.
|
artikel
|
| 16 |
Differences in physical, mental, and social functions between males and females in multiple sclerosis: A multicenter cross-sectional study in China
|
Zhao, Zhengyang
|
|
|
48 |
C |
p.
|
artikel
|
| 17 |
Effect of Ozanimod on Symbol Digit Modalities Test Performance in Relapsing MS
|
DeLuca, John
|
|
|
48 |
C |
p.
|
artikel
|
| 18 |
Experience of South American MS and/or NMOSD experts in practice during the COVID-19 pandemic: Focus on Telemedicine
|
Alonso, Ricardo
|
|
|
48 |
C |
p.
|
artikel
|
| 19 |
Expression and significance of aquaporin-4 in thyroid carcinoma
|
Zhang, Yan-hui
|
|
|
48 |
C |
p.
|
artikel
|
| 20 |
Factors influencing patients’ willingness-to-pay for disease-modifying therapies for multiple sclerosis
|
Poudel, N.
|
|
|
48 |
C |
p.
|
artikel
|
| 21 |
Fingolimod treatment reverses signs of diffuse white matter damage in multiple sclerosis: A pilot study
|
Saraste, Maija
|
|
|
48 |
C |
p.
|
artikel
|
| 22 |
First line treatment failure: Predictive factors in a cohort of 863 Relapsing Remitting MS patients
|
Ayrignac, Xavier
|
|
|
48 |
C |
p.
|
artikel
|
| 23 |
FLAIR-hyperintense lesions in anti-MOG-associated encephalitis with seizures (FLAMES) unmasked by withdrawal of immunosuppression for Crohn's disease?
|
Stamenova, Svetlana
|
|
|
48 |
C |
p.
|
artikel
|
| 24 |
Frequency of comorbidities in Neuromyelitis Optica spectrum disorder
|
Barzegar, Mahdi
|
|
|
48 |
C |
p.
|
artikel
|
| 25 |
How may patients with MS benefit from using music assisted therapy? A case-control feasability study investigating motor outcomes and beyond.
|
Maggio, Maria Grazia
|
|
|
48 |
C |
p.
|
artikel
|
| 26 |
Immune phenotyping study revealing caveats regarding a switch from fingolimod to cladribine
|
Radlberger, RF
|
|
|
48 |
C |
p.
|
artikel
|
| 27 |
Immunogenicity of The Influenza Vaccine in Multiple Sclerosis Patients: A Systematic Review and Meta-Analysis
|
Nguyen, Jackie
|
|
|
48 |
C |
p.
|
artikel
|
| 28 |
Impact of psychiatric distress and physical disability on quality of life in neuromyelitis optica spectrum disorder and chronic autoimmune demyelinating polyneuropathies
|
Yalachkov, Yavor
|
|
|
48 |
C |
p.
|
artikel
|
| 29 |
Impact of Rituximab on relapse rate and disability in an Ecuadorian cohort of patients with neuromyelitis optica spectrum disorders
|
Correa-Díaz, Edgar Patricio
|
|
|
48 |
C |
p.
|
artikel
|
| 30 |
Influence of delaying ocrelizumab dosing in multiple sclerosis due to COVID-19 pandemics on clinical and laboratory effectiveness
|
Barun, Barbara
|
|
|
48 |
C |
p.
|
artikel
|
| 31 |
Interleukin-6 inhibition with tocilizumab for relapsing MOG-IgG associated disorder (MOGAD): A case-series and review
|
Elsbernd, Paul M.
|
|
|
48 |
C |
p.
|
artikel
|
| 32 |
Introduction of the Watzmann Severity Scale: A sensorimotor approach to estimate the course of inpatient rehabilitation in multiple sclerosis
|
Gulde, P.
|
|
|
48 |
C |
p.
|
artikel
|
| 33 |
Late-onset Leber's hereditary optic neuropathy presenting with longitudinally extensive myelitis harbouring the m.14484T>C mutation: Extending the genotype-phenotype spectrum
|
Cleaver, Jonathan
|
|
|
48 |
C |
p.
|
artikel
|
| 34 |
Late-onset MADD in Yemen caused by a novel ETFDH mutation misdiagnosed as ADEM
|
Lian, Ling
|
|
|
48 |
C |
p.
|
artikel
|
| 35 |
Longitudinally extensive transverse myelitis following acute COVID-19 infection
|
Fumery, Thibault
|
|
|
48 |
C |
p.
|
artikel
|
| 36 |
Low-dose tacrolimus in treating neuromyelitis optica spectrum disorder
|
Wang, Liang
|
|
|
48 |
C |
p.
|
artikel
|
| 37 |
Neuro-ophthalmologic manifestations of multiple sclerosis other than acute optic neuritis
|
Costa Novo, Joana
|
|
|
48 |
C |
p.
|
artikel
|
| 38 |
Perceived discrimination in patients with multiple sclerosis and depressive symptomatology
|
Ochoa-Morales, A
|
|
|
48 |
C |
p.
|
artikel
|
| 39 |
Personality of patients with multiple sclerosis and the use of hippotherapy
|
Dziubek, Anna
|
|
|
48 |
C |
p.
|
artikel
|
| 40 |
Physiotherapy use and access-barriers in persons with multiple sclerosis: A cross-sectional analysis
|
Fortunato, Remo
|
|
|
48 |
C |
p.
|
artikel
|
| 41 |
Predicting long walking capacity from the timed 25-foot walk test in persons with multiple sclerosis – a potential simple aid to assist ambulation scoring?
|
Ramari, Cintia
|
|
|
48 |
C |
p.
|
artikel
|
| 42 |
Pregnancy outcomes in women with Multiple Sclerosis
|
Soler, Bernardita
|
|
|
48 |
C |
p.
|
artikel
|
| 43 |
Prevalence of adverse pregnancy outcomes after exposure to interferon beta prior to or during pregnancy in women with MS: Stratification by maternal and newborn characteristics in a register-based cohort study in Finland and Sweden
|
Korjagina, Marta
|
|
|
48 |
C |
p.
|
artikel
|
| 44 |
Preventing multiple sclerosis misdiagnosis using the “central vein sign”: A real-world study
|
Kaisey, Marwa
|
|
|
48 |
C |
p.
|
artikel
|
| 45 |
Primary progression in NMOSD. Does it really exist?
|
Parissis, Dimitrios
|
|
|
48 |
C |
p.
|
artikel
|
| 46 |
Protective effects of cognitive and brain reserve in multiple sclerosis: Differential roles on social cognition and ‘classic cognition’
|
Machado, Rita
|
|
|
48 |
C |
p.
|
artikel
|
| 47 |
Retinal cotton wool spot associated with cladribine therapy for multiple sclerosis
|
Gummi, Ravali
|
|
|
48 |
C |
p.
|
artikel
|
| 48 |
Risk factors for infusion-related reactions following Ocrelizumab infusion in a community setting: Development of an electronic medical record-based explanatory model
|
O'Nell-Meyer, Hollis
|
|
|
48 |
C |
p.
|
artikel
|
| 49 |
Safety and efficacy of low-dose medical cannabis oils in multiple sclerosis
|
S, Gustavsen
|
|
|
48 |
C |
p.
|
artikel
|
| 50 |
Serum vitamin d inversely correlates with depression scores in people with multiple sclerosis
|
El-Salem, Khalid
|
|
|
48 |
C |
p.
|
artikel
|
| 51 |
Telephone validation of an Urdu translated version of the extended disability severity scale in multiple sclerosis patients
|
Syed, Maryam J.
|
|
|
48 |
C |
p.
|
artikel
|
| 52 |
Time interval between disease onset and MS diagnosis during the last decades in Latin America
|
Rojas, Juan I.
|
|
|
48 |
C |
p.
|
artikel
|
| 53 |
Timing of plasma exchange for neuromyelitis optica spectrum disorders: A meta-analysis
|
Huang, Xiaoxia
|
|
|
48 |
C |
p.
|
artikel
|
| 54 |
Tumefactive multiple sclerosis (TMS): A case series of this challenging variant of MS
|
Villarreal, Joseph V.
|
|
|
48 |
C |
p.
|
artikel
|
| 55 |
Underutilization of physical therapy for symptomatic women with MS during and following pregnancy
|
Block, Valerie J
|
|
|
48 |
C |
p.
|
artikel
|
| 56 |
Validation of the French version of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS)
|
Maubeuge, Nicolas
|
|
|
48 |
C |
p.
|
artikel
|
| 57 |
Word cloud for hospitalization admission diagnoses in patients with multiple sclerosis
|
Vislay-Wade, Rebecca L.
|
|
|
48 |
C |
p.
|
artikel
|
Tijdschrift beschrijving